Clinical Trial Update: BIO-SHORT: Biologically Guided Short-Course Hypofractionated RT for Poor-Prognosis GBM [Phase 2]

View source ↗

Summary

BIO-SHORT is a Phase 2 trial evaluating biologically guided short-course hypofractionated radiotherapy for poorly prognostic glioblastoma. The study is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Glioma

Snippet

Sponsor: Tata Memorial Centre | Conditions: Glioma | Phase 2 | Status: RECRUITING